Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial

MLA

Patricia B Pavlinac, PhD, et al. “Azithromycin for the Prevention of Rehospitalisation and Death among Kenyan Children Being Discharged from Hospital: A Double-Blind, Placebo-Controlled, Randomised Controlled Trial.” The Lancet Global Health, vol. 9, no. 11, Nov. 2021, pp. e1569–78. EBSCOhost, https://doi.org/10.1016/S2214-109X(21)00347-8.

APA

Patricia B Pavlinac, P., Benson O Singa, Mbc., Kirkby D Tickell, M., Rebecca L Brander, P., Christine J McGrath, P., Mary Amondi, B., Joyce Otieno, D., Elizabeth Akinyi, Bs., Doreen Rwigi, Bs., Joseph D Carreon, M., Stephanie N Tornberg-Belanger, M., Ruth Nduati, Mm., Joseph B Babigumira, P., Liru Meshak, Mbc., George Bogonko, Mm., Samuel Kariuki, P., Barbra A Richardson, P., Grace C John-Stewart, M., & Judd L Walson, M. (2021). Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial. The Lancet Global Health, 9(11), e1569–e1578. https://doi.org/10.1016/S2214-109X(21)00347-8

Chicago

Patricia B Pavlinac, PhD, MbChB Benson O Singa, Mbbs Kirkby D Tickell, PhD Rebecca L Brander, PhD Christine J McGrath, Ba Mary Amondi, Dip Joyce Otieno, et al. 2021. “Azithromycin for the Prevention of Rehospitalisation and Death among Kenyan Children Being Discharged from Hospital: A Double-Blind, Placebo-Controlled, Randomised Controlled Trial.” The Lancet Global Health 9 (11): e1569–78. doi:10.1016/S2214-109X(21)00347-8.